FDA approves Amgen drug for secondary hyperparathyroidism
admin 27th February 2017 Uncategorised 0American Pharmacists Association News More: FDA approves Amgen drug for secondary hyperparathyroidism Source: MDlinx
read moreAmerican Pharmacists Association News More: FDA approves Amgen drug for secondary hyperparathyroidism Source: MDlinx
read morePharmacy Times More: FDA approves test to detect antibiotic sensitivity in blood infections Source: MDlinx
read moreGenmab More: CHMP issues positive opinion recommending DARZALEX® (daratumumab) for relapsed or refractory multiple myeloma Source: MDlinx
read more© 1994 - 2023 B.M. Pharmaceuticals